A new study has shown that a common cholesterol medication could help to slow the symptoms of Alzheimer's disease. The research, which was undertaken by scientists in Sweden, suggests that statin ...

The efficacy data could help cushion Ibrance's losses of market share to Kisqali, a similar drug from Novartis.

A new groundbreaking study showed that a common cholesterol-lowering blood pressure medication could slow cognitive decline ...